Shamoon, S., ALZubaidi, M. (2025). Insulin treatment regimen of type 1 diabetic children and adolescents attending Children Welfare Teaching Hospital/ Medical City. , 24(2), 159-166. doi: 10.52573/ipmj.2025.137585
Swalin Shamoon; Munib ALZubaidi. "Insulin treatment regimen of type 1 diabetic children and adolescents attending Children Welfare Teaching Hospital/ Medical City". , 24, 2, 2025, 159-166. doi: 10.52573/ipmj.2025.137585
Shamoon, S., ALZubaidi, M. (2025). 'Insulin treatment regimen of type 1 diabetic children and adolescents attending Children Welfare Teaching Hospital/ Medical City', , 24(2), pp. 159-166. doi: 10.52573/ipmj.2025.137585
Shamoon, S., ALZubaidi, M. Insulin treatment regimen of type 1 diabetic children and adolescents attending Children Welfare Teaching Hospital/ Medical City. , 2025; 24(2): 159-166. doi: 10.52573/ipmj.2025.137585

Insulin treatment regimen of type 1 diabetic children and adolescents attending Children Welfare Teaching Hospital/ Medical City

Iraqi Postgraduate Medical Journal
Article 2, Volume 24, Issue 2, April 2025, Pages 159-166    PDF (458.18 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2025.137585
Authors
Swalin Shamoon* 1; Munib ALZubaidi2
1faculty of medicine, kirkuk university, kirkuk, iraq
2Pediatrics, faculty of medicine, university of Baghdad, Baghdad, Iraq
Abstract
Background:

Insulin therapy is the cornerstone treatment of tT1DM in children and adolescents. Various insulin types and modes of administration are available with various efficacy and safety.

Aim of the study:

To evaluate the difference in efficacy between conventional regimen and multiple daily doses in treatment and control of T1DM among children and adolescents.

Patients and methods:

This study is a clinical prospective follow-up study conducted in Diabetic clinic of Children Welfare Teaching Hospital at Medical Complex in Baghdad city-Iraq for 10 months duration from 1st of December, 2020 till 30th of September, 2021 on an acceptable sample of 75 children and adolescents with type I diabetes mellitus divided into two groups; group I (50 children treated by conventional insulin therapy) and group II (25 children treated by basal-bolus dose insulin therapy). The outcomes held up were the number of diabetic ketoacidosis attacks & causes, the number of hypoglycemia attacks & causes, anthropometric measures (weight, height & body mass index), and HbA1c level. The children and adolescents with type I diabetes were followed up by direct contact for 6 months period from 1st visit to 2nd visit with a phone call and follow-up record of the outcomes.

Results:

Mean HbA1c level of group II diabetic children were significantly lower than mean HbA1c of group I diabetic children at 2nd visit (p<0.001) with no significant difference in weight, height, and body mass index between the two study groups. The growth velocity was calculated and in comparison, between conventional insulin therapy and multiple daily injection regime, no significant difference was observed (P>0.05). The insulin dose/Kg is increased in type I diabetic children and adolescents treated with multiple daily injections regimens.

Conclusions:

The multiple daily injections regimen of insulin therapy for type I diabetic children and adolescents is more effective in glycemic control.
Keywords
insulin,,; ,،؛type 1 diabetes,,; ,،؛insulin pens,,; ,،؛glargine
References
  1. Ziegler R, Neu A. Diabetes in Childhood and Adolescence. Dtsch Arztebl Int 2018;115:146-56.
  2. Tuomilehto J. The emerging global epidemic of type 1 diabetes. Curr Diab Rep 2013;13:795-804.
  3. Mamoulakis D, Galanakis E, Bicouvarakis S, Paraskakis E, Sbyrakis S. Epidemiology of childhood type I diabetes in Crete, 1990–2001. Acta Paediatr 2003;92:737-39.
  4. Almahfoodh D, Alabbood M, Alali A, Mansour A. Epidemiology of type 1 diabetes mellitus in Basrah, Southern Iraq: A retrospective study. Diab Res Clin. Pract 2017;133:104-8.
  5. AL-Rubaee RJ. Newly diagnosed type 1 Diabetes Mellitus in Dhi-qar City (IRAQ) sociodemographic study. IOSR Journal of Dental and Medical Sciences 2013;10:53-62
  6. Britta M. Svoren, Nicholas Jospe. Diabetes mellitus in children, in Robert M. Kleigman, Bonita F. Stanton, Joseph W. St Geme, Nina F. Schor. Nelson Textbook of Pediatrics, 21st Edition. Philadelphia, Elsevier 2020:2760-90.
  7. Mark A. Sperling, William V. Tamborlane, Tadej Battelino, Stuart A. Weunzimer, Moshe Phillip. Diabetes mellitus, in: Mark A. Sperling. Pediatric Endocrinology, 5th edition. Elsevier, Saunders 2021: 846-900.
  8. Donner T, Sarkar S. Insulin – Pharmacology, Therapeutic Regimens, and Principles of Intensive Insulin Therapy. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278938/
  9. Cowie CC, Rust KF, Byrd-Holt DD. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care 2010;33:562–68.
  10. Nowicka P, Santoro N, Liu H. Utility of hemoglobin A1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 2011;34:1306–11.
  11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
  12. Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K; Pediatric Study Group of Insulin Glargine. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15:369-76.
  13. Selam JL. Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol 2010; 4:505-13.
  14. Selam JL. CSII in Europe: an analysis of articles published in Infusystems International. Infusystems Int 2007; 6:14–16.
  15. Alderisio A, Bozzetto L, Franco L, Riccardi G, Rivellese AA, Annuzzi G, et al. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study. Nutr Metab Cardiovasc Dis 2019; 29:1110-17.
  16. Wang X, Zhao X, Chen D, Zhang M, Gu W. Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Pediatric Type 1 Diabetes: A Meta‐Analysis and Prospective Cohort Study. Front Endocrinol 2021;12:608232.
  17. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes--causes, effects and coping strategies. Diabetes Obes Metab 2007;9:799-812.
  18. Santi E, Tascini G, Toni G, Berioli MG, Esposito S. Linear Growth in Children and Adolescents with Type1 Diabetes Mellitus. Int J Environ Res Public Health. 2019;16(19):3677.
  19. Al-Mendalawi M. Switching to Multiple Daily Insulin Injections in Children and Adolescents with Type 1 Diabetes: A Question of Standards. Oman Med J 2015; 30: 307-8.
  20. Sharef SW, Ullah I, Al-Shidhani A, Al-Farsi T, Al-Yaarubi S. Switching to multiple daily insulin injections in children and adolescents with type 1 diabetes: revisiting benefits from Oman. Oman Med J 2015; 30:83-89.
  21. Herbert LJ, Wall K, Monaghan M, Streisand R. Parent Employment and School/Daycare Decisions among Parents of Young Children with Type 1 Diabetes. Child Health Care 2017;46:170-80.
  22. Jeraiby M. Awareness of Preconception Care and Its Related Factors Among Women of Childbearing Age with Type 1 Diabetes in the South of Saudi Arabia: A Cross-Sectional Survey Study. Int J Gen Med 2021; 14:8583-89.
  23. Gomes MB, Negrato CA, Cobas R, Gonçalves PR, da Silva PCB, Carneiro JRI, et al. Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in Brazil. Diabetol Metab Syndr 2014;6:67. Available from: https://doi.org/10.1186/1758-5996-6-67.
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Statistics
Article View: 254
PDF Download: 139


Journal Management System. Powered by iJournalPro.com